Pilot/Feasibility Core
$80,750U54FY2023NSNIH
University Of California, San Francisco, San Francisco CA
Investigators
Linked publications & trials
Paper 39175387Paper 38660801Paper 38631080Paper 38517485Paper 38415136Paper 38050014Paper 37470933Paper 37089589Paper 37048789Paper 36902347Paper 36695309Paper 36521316Paper 35635655Paper 35456471Paper 35442860Paper 35145012Paper 35110554Paper 35109678Paper 35084939Paper 34538258Paper 34491620Paper 34479577Paper 34454271Paper 34398721Paper 34185176Paper 34153815Paper 33894400Paper 33816125Paper 33813331Paper 33796444Paper 33748556Paper 33560189Paper 33493737Paper 33407668Paper 33343397Paper 33316689Paper 33214184Paper 33122213Paper 33080889Paper 33070883Paper 32912090Paper 32842615Paper 32771470Paper 32524545Paper 32467778Paper 32467184Paper 32461638Paper 32100472Paper 31825263Paper 31776290Paper 31643041Paper 31526690Paper 30909834Paper 30853154Paper 30584075Paper 30512964Paper 30482419Paper 30140608Paper 30112971Paper 29932521Paper 29844917Paper 29803545Paper 28973426Paper 28757309Paper 28711177Paper 28639385Paper 28534135Paper 28489816Paper 28318403Paper 28157749Paper 27864521Paper 27399362Paper 27320373Paper 27268758Paper 27194034Paper 27009946Paper 26997037Paper 26795600Paper 26706016Paper 26564078Paper 25952468Paper 25928712Paper 25900426Paper 25858236Paper 25847705Paper 25572952Paper 25565562Paper 25556204Paper 25472749Paper 25439578Paper 25344741Paper 25221778Paper 25140883Paper 24401931Paper 24323376Paper 23907585Paper 23828561Paper 23720035Paper 23656586Paper 23112247
Abstract
Abstract The goal of the Pilot/Feasibility Projects Core (PFP) is to fund promising projects that take advantage of new clinical research opportunities in HHT, CCM, SWS, or other rare diseases thematically related to the BVMC. These projects will demonstrate feasibility and generate proof-of-concept data for future grant funding, and are aimed at diagnosis or management/treatment of BVMC related diseases. They will have potential for high impact one or more of the BVMC diseases, with particular emphasis on clinical trial readiness. We will support a minimum of 3 or a maximum of 5 pilot projects (one per year).
View original record on NIH RePORTER →